We are changing the aesthetics industry by offering a unique portfolio of leading brands to best meet the needs of your aesthetics patients along their path to rejuvenation.
Our goal is to equip you with the comprehensive set of tools you need to provide the outcomes your patients desire and create greater value for your practice.
The only aesthetics company offering solutions in injectables, professional skincare, laser and other aesthetics devices, united under one mission:
Empowering the expert. Empowering outcomes.
March 12, 2014
Dear Valeant Aesthetic Customers,
2013 was a busy and exciting year for Valeant. The year started with the integration of Medicis and just three months later we completed the acquisition of Obagi Medical Products. Recently, we finalized the acquisitions of Solta Medical and IF Marketing as well as an exciting partnership with Living Proof. These recent developments represent further steps in our expanding commitment to aesthetic practices and patients. Today, our product portfolio stretches across key areas of aesthetics and enables you to offer a variety of in-demand procedures to every patient that enters your practice in search of an optimal outcome.
Your patients come to you because they trust you as specialists in this space, capable of providing the outcomes they desire. Whether a patient comes to you to address a minor blemish that bothers them or in search of a global make-over that optimizes their appearance, we hope to provide you with all the tools you require to address their needs. Every patient that comes through your door is embarking on a journey- one that has the power to provide them with the confidence they need to live the lives to which they aspire. Their trust in you is vital and we know you take your role in every patient’s journey seriously. We take our role as your partner in this effort just as seriously, and look forward to continuing to build our relationship with you for many years to come.
I want to take this opportunity to provide a recap of some of our news from the past year and to share some insight on our business.
In 2014, you will see an increased commitment from the Valeant Aesthetics Team to you and aesthetic practices everywhere. Our portfolio will continue to expand through the addition of products in development as well as continued acquisitions and partnerships. We hope to bring products to your office that meet unmet needs and provide compelling solutions for your customers while bringing you new business opportunities. Neotensil™ is just one example. Our growing sales force will be able to better meet your needs and support your practices at a high level and the addition of the IF Marketing Team will provide you with opportunities to purchase tools and services that will drive patient value, procedural growth, and increased revenues. You have our commitment.
Thank you for your support in 2013. We look forward to working even more closely with you in 2014 and beyond.
Executive Vice President & Company Group Chairman
Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of Dysport and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and at lower doses.
The potency Units of Dysport are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of Dysport cannot be compared to or converted into units of any other botulinum toxin products assessed with any other specific assay method.